SII Q-VAC Vaccine is a quadrivalent vaccine developed by Serum Institute of India (SII) to provide active immunization against four strains of human papillomavirus (HPV): types 6, 11, 16, and 18. These HPV types are associated with the majority of cervical cancers and genital warts. The vaccine is designed to help prevent HPV-related diseases in individuals prior to exposure to the virus.

• Provides protection against HPV types 6, 11, 16, and 18

• Helps prevent cervical cancer and genital warts

• Contributes to reducing the burden of HPV-related diseases

• Suitable for pre-adolescent and adolescent girls and boys before exposure to HPV

• Administered as an intramuscular injection for effective immune response

• Administered by healthcare professionals via intramuscular injection, typically in the deltoid muscle.

• Given as part of a vaccination schedule, usually involving two or three doses over six months.

• Follow the immunization timetable recommended by healthcare providers or national guidelines.

• Each dose contains antigens for HPV types 6, 11, 16, and 18.

• Typically administered as a series of 2 or 3 doses depending on the age at initiation.

• Booster doses may be recommended according to local health policies.

• Safe and well-tolerated in eligible individuals.

• Inform healthcare providers of any allergies or previous adverse vaccine reactions.

• Mild side effects such as pain at injection site or low-grade fever may occur.

• Severe allergic reactions are rare but require immediate medical attention.

• Not recommended during acute severe illness; consult healthcare provider before administration.

• Common: injection site pain, redness, swelling, mild fever, headache

• Rare: allergic reactions including rash, swelling, or anaphylaxis

• Contact your healthcare provider if you experience any severe or unusual side effects.

• Store vaccine vials refrigerated at 2°C to 8°C (36°F to 46°F).

• Protect from light and do not freeze.

• Use before the expiration date indicated on the packaging.

• Keep out of reach of children.

Q: Who should receive the SII Q-VAC Vaccine?
A: Recommended for pre-adolescent and adolescent boys and girls, ideally before the onset of sexual activity.

Q: How many doses are required?
A: Typically, 2 or 3 doses are administered over a period of 6 months.

Q: Can the vaccine be given with other routine immunizations?
A: Yes, it can be co-administered with other vaccines as per healthcare provider recommendations.

Q: Is the vaccine effective against all HPV types?
A: The vaccine protects against the four most common HPV types responsible for cervical cancer and genital warts but does not cover all HPV strains.